Environmental, Social, Governance

Corporate Social Responsibility (CSR) is an integral part of Sanofi’s core business strategy. By building a pragmatic and innovative approach to meet today’s CSR challenges, it contributes to value creation and improving our business.

The Corporate Social Responsibility department, in coordination with the Investor Relations department, is in charge of the information analyzed by socially responsible investors and rating agencies which assess companies according to social, environmental, economic and governance criteria.

Sanofi CSR strategy is driven by material issues defined with the input of our stakeholders

Our stakeholders

Read the full infographic

CSR Strategy embedded in the Business

Sanofi’s contribution goes beyond medical care. Whether improving access to care, reducing our environmental footprint, or taking on the role of a responsible corporate citizen in other ways, we want to make sure that Corporate Social Responsibility is embedded into all of our activities.

Our reporting principles are based on the Global Reporting Initiative (GRI) standards, under the “Core” option. Sanofi is also a signatory of the United Nations Global Compact.

Sanofi publishes an Integrated Report based on the International Integrated Reporting Council (IIRC) framework. It presents, in a synthetic manner, the Group’s strategy for creating short, mid- and long-term value (financial and extra-financial) for the company and its stakeholders.
Sanofi also publishes in its French registration document (Document d’Enregistrement Universel) a chapter on Corporate Social Responsibility (Chapter 4) which includes our Statement of Extra Financial Performance (DPEF). An English translation of this chapter is available below.
CSR indicators and the auditors’ report are reported in the factsheet CSR Indicators Table and Auditor’s Report, see below.
Other reference documents and factsheets are available in the Document Center of the “Our Responsibility” section (see below).

Quick links

Recognition for our extra-financial performance

Sanofi’s performance is recognized through our inclusion in the most important international Socially Responsible Investment (SRI) indices including:

Dow Jones Sustainability Index (DJSI) World (Bronze Class): reference index in sustainable Development
FTSE4Good (Financial Times Stock Exchange)
Access to Medicine Index (ATM)
Stoxx® Global ESG Leaders indices

Extra-financial performance

SANOFI rankings & scores - 2018/2019
	DJSI Included in 2019 DJSI World for the 13^th consecutive year Included in the DJSI Europe	Score 82/100 3^rd among 61 pharmaceuticals companies
	MSCI	Score: A (Scale from CCC to AAA) 3^rd among the 5 largest pharmaceutical companies
	Sustainalytics (2018)	Score 71/100 4^th among 160 pharmaceutical companies
	Global 100 Clean 200	28th among 100⁽²⁾ 22^ndamong 200 (all industry sectors)
	ISS-ESG⁽³⁾	Score: B (Scale from D- to A+) Sanofi among top 3 pharmaceuticals leaders
	FTSE4Good	Score: 4,4/5
	CDP Climate Change	Score: B
	CDP Water	Score: A-
	ATM index (2020)	5^th among 20 pharmaceutical companies